Adaptive Biotechnologies ... (ADPT)

8.13

-0.13 (-1.57%)

At close: Mar 03, 2025, 3:59 PM

8.10

-0.31%

After-hours: Mar 03, 2025, 04:55 PM EST

Adaptive Biotechnologies Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-225.25M	-200.37M	-207.3M	-146.23M	-68.61M	-46.45M	-42.83M
Depreciation & Amortization	22.23M	20.92M	13.95M	8.47M	7.79M	6M	5.8M
Stock-Based Compensation	62.91M	55.48M	43.25M	24.76M	13.12M	11.15M	7.01M
Other Working Capital	-44.2M	-56.83M	-49.48M	-43.66M	266.41M	-1.32M	1.49M
Other Non-Cash Items	29.97M	11.57M	6.95M	3.34M	43K	5K	6K
Deferred Income Tax	n/a	n/a	7.23M	773K	-1.88M	-1.24M	637K
Change in Working Capital	-46.18M	-71.55M	-56.82M	-40.8M	254.93M	-1.72M	-5.47M
Operating Cash Flow	-156.32M	-183.94M	-192.73M	-149.68M	205.4M	-32.26M	-34.86M
Capital Expenditures	-10.7M	-16.35M	-61.75M	-18.8M	-11.2M	-6.32M	-2.51M
Acquisitions	n/a	-19.25M	-181.21M	98.24M	470.5M	19K	85K
Purchase of Investments	-429.56M	-278.78M	-316.54M	-694.97M	-884.22M	-146.5M	-125.18M
Sales Maturities Of Investments	569.9M	298.03M	559.5M	596.72M	413.72M	153.54M	163.91M
Other Investing Acitivies	-1	19.25M	181.21M	-98.24M	-470.5M	19K	122K
Investing Cash Flow	129.65M	2.9M	181.21M	-117.04M	-481.7M	736K	36.43M
Debt Repayment	n/a	124.38M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.25M	7.89M	27.15M	21.43M	-934K	1.25M	50.03M
Financial Cash Flow	2.25M	132.26M	27.15M	293.59M	319.92M	1.25M	50.03M
Net Cash Flow	-24.43M	-48.77M	15.63M	26.86M	43.62M	-30.27M	51.61M
Free Cash Flow	-167.02M	-200.29M	-254.47M	-168.49M	194.2M	-38.58M	-37.36M